-
Loading metrics
Open Access
Peer-reviewed
Research Article
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
-
James F Curtin,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Naiyou Liu,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Marianela Candolfi,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Weidong Xiong,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Hikmat Assi,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Kader Yagiz,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Matthew R Edwards,
Affiliation Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Kathrin S Michelsen,
Affiliation Inflammatory Bowel Disease Center and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Kurt M Kroeger,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Chunyan Liu,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
A. K. M. Ghulam Muhammad,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Mary C Clark,
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America
⨯ -
Moshe Arditi,
Affiliation Division of Pediatric Infectious Diseases, Cedars Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Begonya Comin-Anduix,
Affiliation Department of Surgery, University of California, Los Angeles, California, United States of America
⨯ -
Antoni Ribas,
Affiliations Department of Surgery, University of California, Los Angeles, California, United States of America , Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America
⨯ -
Pedro R Lowenstein ,
*To whom correspondence should be addressed. E-mail: castromg@cshs.org (MGC); lowensteinp@cshs.org (PRL)
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America , Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America , The Brain Research Institute, University of California, Los Angeles, California, United States of America
⨯ - [ ... ],
-
Maria G Castro
*To whom correspondence should be addressed. E-mail: castromg@cshs.org (MGC); lowensteinp@cshs.org (PRL)
Affiliations Board of Governors' Gene Therapeutics Research Institute and Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, United States of America , Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America , The Brain Research Institute, University of California, Los Angeles, California, United States of America
⨯ - [ view all ]
- [ view less ]
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- James F Curtin,
- Naiyou Liu,
- Marianela Candolfi,
- Weidong Xiong,
- Hikmat Assi,
- Kader Yagiz,
- Matthew R Edwards,
- Kathrin S Michelsen,
- Kurt M Kroeger,
- Chunyan Liu
- Published: January 13, 2009
- https://doi.org/10.1371/journal.pmed.1000010